Category: Stock Market

I believe owning Coles Group Ltd (ASX: COL) shares is a great option for dividends because of both its consistently rising passive income and the size of the dividend yield.

On top of the pleasing dividend, Coles has a defensive earnings base – we all need to eat, of course.

The business has grown its dividend each year since it was listed several years ago, and we’re going to take a look at how large the dividend could grow in the coming years.

FY26

Coles has started FY26 strongly, in the first quarter of FY26, it delivered group total sales revenue of $10.96 billion, representing 3.9% growth – this beat UBS’ expectations.

Broker UBS said that Coles supermarkets are executing strongly and leveraging key investments.

Those investments include Witron automated distributed centres, which are improving product availability in NSW and Queensland. Ocado customer fulfilment centres (CFCs) helped drive 28% online sales growth in the FY26 first quarter.

UBS also pointed out that Coles supermarkets are delivering ongoing promotional effectiveness, which are fewer and better, and product ranging is better (which is increasingly store-led), according to UBS. Both of these advantages have been enabled by the supply chain.

With the effective execution of its strategy, UBS is projecting that the business could decide to pay an annual dividend per share of 79 cents following an increase of the company’s net profit.

If Coles does decide to pay that projected amount, it would mean a grossed-up dividend yield of 5.2%, including franking credits.

FY27

The company could see further dividend growth in the 2027 financial year, thanks to the strength of its revenue and net profit.

UBS is forecasting the business could grow its dividend to a pleasing 93 cents per share in FY27. If that comes true, it would translate into a grossed-up dividend yield of 6.1%, including franking credits, at the current Coles share price.  

FY28

The 2028 financial year could get even better for owners of Coles shares.

In FY28, the board of directors of Coles is projected by UBS to declare an annual dividend per share of 97 cents. If that happens, the business could have a grossed-up dividend yield of 6.3%.

FY29

The broker is projecting that the business could deliver more profit and dividend growth for investors in FY29. UBS is currently suggesting the Coles annual dividend per share could climb to $1.01.

If that happens, Coles would deliver investors a grossed-up dividend yield of 6.6%, including franking credits, using the valuation at the time of writing.

FY30

The final year of this series of projections is expected to see the biggest dividend of all.

UBS forecasts that Coles may deliver investors an annual dividend per share of $1.04. That means the business could provide a grossed-up dividend yield of 6.8%, including franking credits.

The post Here’s the dividend forecast out to 2030 for Coles shares appeared first on The Motley Fool Australia.

More reading

• 3 ASX 200 large-cap shares just re-rated by analysts
• 3 ASX blue-chip shares I’d buy with $3,000 right now
• Brokers rate these 3 top ASX shares as buys in December
• 5 best Australian dividend stocks to buy in December
• 2 top ASX dividend shares for retirees

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

There are a number of reasons why ASX blue-chip shares usually make strong investments each year. Stability, strong earnings generation each year and (usually) a good dividend yield together can be very appealing.

I wouldn’t focus purely on the dividend income. I think it’s a good idea for investors to ensure that the target business has a good outlook for earnings growth too, otherwise the dividends may not be reliable, with the share price lacking that organic tailwind.

The two ASX blue-chip shares I’m going to highlight both have strong dividend yields.

Telstra Group Ltd (ASX: TLS)

The Australian telecommunications giant is one of the most impressive names for payouts because of how generous it is with its dividend payout ratio. In recent times, it has paid out close to all of its net profit generation each year, though it has held onto a higher proportion of its cash earnings.

The company has invested significant sums into its spectrum assets and 5G network to ensure that it has the most appealing network for customers. More subscribers mean the business can spread its costs across more users.

We saw this effect in the FY25 result, with mobile revenue climbing 3% and operating profit (EBITDA) climbing 5%.

I’m expecting the company’s EBITDA and net profit margin to slowly rise over the rest of the decade. I’m particularly optimistic this can happen if Telstra can win more broadband customers onto its wireless (5G-powered) offering, which would enable a higher margin from that household (rather the margin going to the NBN).

I think it’s quite likely the ASX blue-chip share will hike its FY26 annual dividend to at least 20 cents per share, which could mean a grossed-up dividend yield of 5.8%, including franking credits. If it paid a dividend of 21 cents per share, it’d be a grossed-up dividend yield of 6%, including franking credits.

Charter Hall Long WALE REIT (ASX: CLW)

The other business I want to highlight for its yield is a real estate investment trust (REIT) that owns a diversified portfolio of properties which are, on average, long-term rental leases.

Charter Hall Long WALE REIT has a weighted average lease expiry (WALE) of around nine years, meaning its rental earnings are locked in for the long-term.

The business owns properties in a number of areas including service stations, hotels and pubs, telecommunication exchanges, data centres, distribution centres and more. I like that this lowers the risk of being too exposed to one subsector.

This REIT has lots of blue-chip tenants, which is one of the reasons why it’s able to provide investors with pleasing defensive earnings. Its rental income (on a per-property basis) is growing thanks to regular rental increases that are either fixed or linked to inflation, providing a tailwind or rental profits and the distribution.

Charter Hall Long WALE REIT is expecting to grow its FY26 distribution to 25.5 cents per security, translating into a forward distribution yield of 6.3% thanks to its 100% distribution payout ratio.

The post 2 ASX blue-chip shares offering big dividend yields appeared first on The Motley Fool Australia.

More reading

• The smart way to make a $25,000 passive income from ASX shares
• Invested in Telstra shares? Here are the dividend dates for 2026
• Why Telstra shares are a retiree’s dream
• Brokers name 3 ASX dividend shares to buy in December
• 2 ASX dividend shares with yields above 6%

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Sigma Healthcare Ltd (ASX: SIG) share is slowly slipping toward this year’s record low of $2.74. Monday it lost another 2% to close at $2.79.

In 2025, the $33 billion dollar pharmacy group has lost 5.2% in value and in the past 6 months 10%. To put this in context, the S&P/ASX 200 Index (ASX: XJO) gained 5.4% this year.

The tumble has left some investors are asking: is Sigma Healthcare share a buy-the-dip opportunity?

Short-term headwinds

The slide in the Sigma Healthcare share reflects growing caution around short-term headwinds. Beneath the turbulence, Sigma remains a major player in Australian health care, and there are reasons to believe its long-term outlook still holds promise.

Sigma is a leading Australian pharmaceutical wholesaler and retail group, supplying medicines and healthcare goods to community pharmacies and operating brands such as Amcal, Discount Drug Stores, and Chemist Warehouse.

Rocketing integration expenses

So why has the price of the ASX healthcare share dropped? A major factor has been a steep increase in transaction and integration costs tied to its recent merger with Chemist Warehouse and restructuring efforts. The extra costs weighed on profitability, and the sharp focus on merger expenses put pressure on investor confidence.

Moreover, past operational missteps have left a mark. A poorly executed enterprise resource planning (ERP) rollout a couple of years ago disrupted supply chains. This triggered customer losses and prompted many pharmacies to re-contract with other wholesalers.

That dented market share and eroded trust in execution, forcing Sigma to restructure and simplify its business.

Powerful Chemist Warehouse synergies

Still, the Sigma Healthcare share also has solid strengths. The company’s recent merger with Chemist Warehouse has dramatically expanded Sigma’s scale, bringing together wholesale, distribution and retail under one roof. This model could deliver powerful synergies.

Additionally, the demographics underpinning demand remain favourable. An ageing population combined with rising demand for over the counter and health-related products gives the company a foundation for long-term stability.

On the flip side, risks remain. The steep integration and merger costs have dented earnings in the near term, making Sigma Healthcare shares vulnerable until those investments begin to pay off.

Is Sigma Healthcare share a buy, hold or sell?

Looking ahead, analysts offer a cautious but mixed picture. Some see value now that the shares are near recent lows, noting that the merger gives Sigma a shot at becoming Australia’s leading pharmacy-wholesale-retail group.

Broker’s recommendations span from strong buy to strong sell with an average target price over 12 months at $3.21, representing 15% upside.

UBS currently has a price target of $3.40, implying a potential gain of 18% over the next year. The broker is also expecting the company to pay an annual dividend of 4 cents per share in the 2026 financial year.

Ord Minnett has a buy recommendation on Sigma Healthcare.

The broker recently noted:

SIG has started strongly in fiscal year 2026, with Chemist Warehouse posting double-digit network sales growth and an upgraded synergies target. Furthermore, we continue to expect upside via the international rollout and private label strategies.

The post Is Sigma Healthcare share a healthy buy, after hitting new lows? appeared first on The Motley Fool Australia.

More reading

• Should I buy Sigma Healthcare shares for the Chemist Warehouse exposure?
• Buy, hold, sell: Sigma Healthcare, CSL, and Lynas shares
• Leading analysts name 3 ASX 200 titans to buy today
• CSL, Sonic, and Sigma Healthcare shares: Buy, hold, or sell?
• 2 top ASX 200 blue-chip shares worth a spot in your portfolio

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week with a small decline. The benchmark index fell 0.1% to 8,624.4 points.

Will the market be able to bounce back from this on Tuesday? Here are five things to watch:

ASX 200 expected to fall again

The Australian share market looks set to fall on Tuesday following a poor start to the week on Wall Street. According to the latest SPI futures, the ASX 200 is poised to open the day 30 points or 0.35% lower. In late trade in the United States, the Dow Jones is down 0.55%, the S&P 500 is 0.5% lower, and the Nasdaq has fallen 0.35%.

Oil prices fall

It could be a poor session for ASX 200 energy shares such as Karoon Energy Ltd (ASX: KAR) and Santos Ltd (ASX: STO) after oil prices fell overnight. According to Bloomberg, the WTI crude oil price is down 2.1% to US$58.81 a barrel and the Brent crude oil price is down 2.1% to US$62.44 a barrel. This was driven by optimism over the Russia-Ukraine peace deal.

Reserve Bank meeting

All eyes will be on the Reserve Bank of Australia today when it makes a decision on Australian interest rates. According to the ASX 30 Day Interbank Cash Rate Futures December 2025 contract, the market is pricing in only a 3% chance of a rate cut at today’s meeting. The big question, though, is whether the central bank will give hints about whether the cuts are over and hikes are coming in 2026.

Hold Cobram shares

Cobram Estate Olives Ltd (ASX: CBO) shares are a fairly valued according to analysts at Bell Potter. This morning, the broker has reaffirmed its hold rating and $2.90 price target on the olive oil producer’s shares. It said: “There is no change to our Hold rating. While offering ~10% EPS CAGR to FY28e (on a R24M basis), CBO trades at ~32x FY26e EPS (R24MA basis). This multiple vs. growth equation does not stand out as relative value in the sector.”

Gold price falls

ASX 200 gold shares Evolution Mining Ltd (ASX: EVN) and Ramelius Resources Ltd (ASX: RMS) could have a subdued session on Tuesday after the gold price fell overnight. According to CNBC, the gold futures price is down 0.6% to US$4,216.7 an ounce. Traders appear cautious ahead of the US Federal Reserve’s interest rate decision this week.

The post 5 things to watch on the ASX 200 on Tuesday appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Charter Hall Group declares interim distribution for 1H FY26
• After smashing 50 record highs in 2025, what’s ahead for the gold price and ASX gold shares like Northern Star in 2026?
• APA Group gains $1bn extra funding capacity after S&P credit rating change
• DigiCo Infrastructure REIT appoints new CEO and sets strategic growth path

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX bank shares make up an important part of many investors’ portfolios. Surprisingly, it is ANZ Group Holdings (ASX: ANZ) that has brought the best returns amongst the big four banks this year. 

Since the start of the year ANZ shares have risen more than 22%.

For context, the S&P/ASX 200 BANKS (ASX: XBK) is up 8.7% in the same period. 

Why the strong rise?

In January, ANZ shares were trading at roughly $28 and hit a yearly high in November of almost $39. 

That’s an increase of more than 35%. 

This was driven by strong business credit, real estate credit growth and investor mortgage growth. 

However since then, the share price has slid almost 10%. 

Analysts at Macquarie indicate this could be due to early signs of revenue underperformance. 

Is there any upside left for ANZ shares?

After such a strong year, investors may feel they have missed the boat on ANZ shares. 

Sentiment is seemingly mixed amongst experts. 

Yesterday, The Motley Fool’s Samantha Menzies reported that Macquarie has neutral rating on ANZ shares with a target price of $35

This indicates the share price is hovering close to fair value. 

However, Greg Burke, Equity Strategist at Wilsons Advisor/Canaccord Genuity said in November that ANZ shares are comfortably the ‘best value’ bank on all key valuation metrics, while offering the most attractive yield.

ANZ has reset its cost base lower and has a strong capital position. ANZ’s 2030 strategy offers a clear pathway to a structurally lower cost-to-income ratio, an improved ROE, and growth in dividends over time. Recent EPS revisions momentum is another relative appeal vs CBA and NAB.

The sentiment out of the Canaccord Genuity Group last month was that outside of CBA shares, valuations in ASX bank shares are more reasonable. 

When excluding index heavyweight CBA, valuations are more reasonable – especially relative to a fully priced ASX 200. 

On average, the Big 4 ex-CBA trade at a modest discount to the market and sit within their historical relative P/E range (vs the ASX 200), albeit towards the upper end. This suggests bank sector valuations are elevated, but not extreme, outside of CBA.

How have the other big four banks performed?

After a bull run to start the year, Commonwealth Bank of Australia (ASX: CBA) shares have cooled off considerably. 

Australia’s largest bank is now relatively flat across 2025, up just 1.2%. 

National Australia Bank Limited (ASX: NAB) has performed better than CBA, rising approximately 9% since the start of the year. 

The second best performing big four bank share this year has been Westpac Banking Corporation (ASX: WBC). 

Westpac shares have risen 18%. 

The post Up 22% in a year! The red-hot ANZ share price is smashing CBA, Westpac and NAB shares appeared first on The Motley Fool Australia.

More reading

• BHP shares surge 8% on their way to reclaiming the No. 1 title from CBA
• Is the NAB share price a buy for passive income?
• Own Westpac shares? Here are the dividend dates for 2026
• How to invest your first $1,000 in the share market the smart way
• ASX 200 mining shares outperform as iron ore and copper prices strengthen

Motley Fool contributor Aaron Bell has positions in National Australia Bank. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The L1 Long Short Fund Ltd (ASX: LSF) is one of the most successful ASX stocks on the Australian share market.

Since duplicating its managed fund into a listed investment company (LIC) back in 2018, this LIC’s portfolio has generated an average return of 12.7% per annum. That stretches to 23.1% per annum over the past five years.

Now, the L1 Long Short Fund is primarily an Australia-focused investment, with ASX stocks making up at least 70% of the fund at any given moment. It is a rather unusual LIC in that it uses a long-short strategy. This involves traditional investing in other shares in hopes of future returns (long investing). But also short-selling companies that it thinks are in for rough times ahead.

This long-short strategy has clearly been effective at generating returns for its investors on the Australian market. But L1 Capital has just launched a new ASX fund that it hopes can replicate the success of its ASX-focused cousin on the international stage.

ASX veterans might find a bell ringing when we mention Platinum Asset Management. Platinum used to be one of the ASX’s most sought-after stock pickers. But a recent run of underperformance has left it struggling. As a consequence, Platinum Asset Management’s Platinum Capital Ltd listed investment company was approached by L1 Capital with a takeover offer. The offer was accepted, and, earlier this month, was merged into a new LIC that will take L1’s long-short strategy to global markets.

That LIC is now known as L1 Global Long Short Fund Ltd (ASX: GLS), and it might be worth a closer look.

An ASX stock that has banked 70% since January?

We’ve already touched on the ASX-focused L1 Long Short Fund’s previous success. Even though the L1 Global Long Short Fund has only been on the ASX in its new form for a few days, stock investors have a preview of its potential success.

In a merger presentation, L1 fund managers Raphael Lamm and Mark Landau seeded an initial version of what has now become the L1 Global Long Short Fund back in January in a trial run of sorts. Between 1 January and 31 October, that trial run returned a whopping 67.5%. 

Past performance is never a guarantee of future success, of course. But no one can deny that this new ASX stock is off to a flying start.

Some of the long positions that can currently be found in the L1 Global Long Short Fund’s portfolio include Alcoa, ING and Zillow. Meanwhile, the fund has shorted US electric car maker Lucid Motors.

L1 will have to keep up its outperformance for new investors to get bang for their buck, though. After an initial grace period, this new ASX stock will charge a management fee of 1.4% per annum. That’s in addition to a performance fee.

The post This new ASX stock has returned 70% since January appeared first on The Motley Fool Australia.

More reading

• Is Sigma Healthcare share a healthy buy, after hitting new lows?
• 5 things to watch on the ASX 200 on Tuesday
• Up 22% in a year! The red-hot ANZ share price is smashing CBA, Westpac and NAB shares
• This ASX dividend share is projected to pay an 8% yield by 2027
• Here’s why Alphabet is the best-performing “Magnificent Seven” stock in 2025 (and why it has room to run in 2026)

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Zillow Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The ASX dividend share Elders Ltd (ASX: ELD) has seen a sizeable valuation decline since 2022, as the chart below shows. This could be a buying opportunity, in my view.

The agricultural business has operations across a wide variety of areas, including farming sector retail products, wholesale products, livestock and wool agency services, storage and handling of wool, feed lots for cattle, real estate sales agency and property management services, financial services (including insurance), digital and technical services (including investments in AuctionsPlus and the Clear Grain Exchange online trading platforms), and own-brand agricultural chemicals and animal health products.

In summary, it’s heavily involved in Australia’s agricultural sector and associated services.

Following the decline of the Elders share price, it could now offer a very large dividend yield for investors by FY27.

Passive income projections

Payouts are decided based on how much profit a company generates as well as how generous the board of directors is feeling.

According to the projection on CMC Markets, the business is forecast to increase its annual payout per share to 36.5 cents. Following that, the ASX dividend share could grow its dividend to 39.5 cents per share in the 2027 financial year.

Using the valuation at the time of writing, this translates into a potential grossed-up yield of 8% including franking credits or 5.6% excluding the franking credits.

Let’s take a look at why now could be a good time to invest in the agricultural business.

Strong outlook for the ASX dividend share?

The earnings per share (EPS) forecasts on CMC Markets suggest the business could deliver 58.2 cents of EPS in FY26 and then 63 cents of EPS in FY27. Based on those projections, the Elders share price is valued at just 11x FY27’s estimated earnings.

When Elders announced its FY25 result, it gave some comments regarding FY26:

Elders is optimistic about the outlook for FY26, supported by a forecast recovery from dry conditions in South Australia and Victoria, as well as the commencement of benefits following implementation of our new retail system. In addition, we welcome Delta Agribusiness to Elders, expanding our Rural Products business in FY26.

The outlook and fundamentals for Australian livestock remain sound with prices for sheep and cattle forecast to be supported by strong international demand against a backdrop of tightening supply, especially from regions recovering from drought. The outlook for the regional residential property market remains positive, benefitting from stabilisation of interest rates at lower levels.

Elders will continue to invest in strategic initiatives, in line with its Eight Point Plan, while maintaining a focus on cost and capital efficiency.

With that in mind, I think the ASX dividend share could be a good under-the-radar buy for long-term investors.

The post This ASX dividend share is projected to pay an 8% yield by 2027 appeared first on The Motley Fool Australia.

More reading

• Macquarie names 3 top dividend-paying ASX 200 shares to buy today
• 3 ASX agriculture shares just re-rated by experts
• What’s driving a 9% divergence in ASX 200 consumer staples vs. discretionary shares?
• Why did the ASX 200 dive to a near six-month low last week?
• Elders shares tipped to climb 11% higher, outlook revised: Here’s why

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Elders. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Let’s turn the calendar back six months to early June. 

Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) was down over 10% year to date, while the S&P 500 had recovered from the tariff-induced sell-off in April and was roughly flat on the year.

Fast-forward to today, and Alphabet is up 67% year to date, has more than doubled off of its 52-week low, and surpassed Microsoft to become the third-most valuable company in the world behind Nvidia and Apple. In 2025, Alphabet is by far the best-performing “Magnificent Seven” stock, with Nvidia in a distant second place with a 35.1% year-to-date gain.

Here’s why Alphabet’s rise wasn’t a fluke, how you can identify Alphabet-like stocks before they pop, and why Alphabet has room to run in 2026. 

Alphabet was epically mispriced

Finance classes will teach you theories such as the efficient market hypothesis, which essentially posits that asset prices are accurately determined based on available information. In practical application, the hypothesis attributes outsize gains to taking on outsize risks — effectively discrediting the finding of true value independent of risk in the market.

Alphabet is a prime example of why the hypothesis is incorrect.

Earlier this year, Alphabet got so cheap that it traded at a discount to the S&P 500. It was the least expensive Magnificent Seven stock, despite the company generating substantial free cash flow, achieving steady high-margin growth, repurchasing a significant amount of stock, paying dividends, and maintaining a solid balance sheet.

Simply put, Wall Street failed to price in Alphabet’s growth potential and labeled it as an artificial intelligence (AI) loser. That assumption couldn’t be further from the truth.

From laggard to leader

Alphabet has a massively diversified business, spanning Google Search, Google Cloud, YouTube, Android, Google services like Gmail and Google Drive, “other bets” like Waymo and Google Fiber, research and development arm Google DeepMind, and more. But despite all these moving parts, Alphabet still depends on Google Search for over half of its revenue and the majority of its operating income.

Large language models (LLMs) present the greatest threat to Google Search in its history. And for a while, there were fears that tools like OpenAI, Claude, Copilot, DeepSeek, Grok, and others would slowly erode Alphabet’s once-dominant share of the search market. If queries shifted from web-based text links to conversational, that would disrupt the very fabric of Google Search’s identity.

Instead of sitting on its hands and letting the LLM wave weather its once-impenetrable moat, Alphabet integrated its model, Gemini, into Google Search, as well as a stand-alone app. Rather than reinvent the wheel, Alphabet essentially upgraded Chrome with AI features, making it more powerful and providing an incentive for users to stay on the platform instead of switching to a different tool entirely.

The strategy worked. Google Search continues to grow despite upgrades from rival LLMs. Alphabet is generating all-time-high earnings and investing heavily in long-term projects, including the expansion of Google Cloud infrastructure. Alphabet is thriving and is far from being a legacy tech giant, with its best days in the rearview mirror. And yet just six months ago, the market was pricing Alphabet like a washed-up relic.

Engagement continues to rise on Gemini — with the app surpassing 650 million monthly active users.

As an added vote of confidence, Berkshire Hathaway announced a stake in Alphabet — marking a stark contrast from quarter after quarter of trimming its Apple position — indicating Warren Buffett and his team perceive Alphabet as a good value.

Meta Platforms is considering purchasing Alphabet’s Tensor Processing Unit (TPU) chips, which Alphabet developed with Broadcom. Custom-made TPUs are a cost-effective solution for data centers, offering a more affordable alternative in certain applications than graphics processing units, such as those manufactured by Nvidia or Advanced Micro Devices.

Flipping the script

Alphabet’s investment thesis has evolved, but the bigger change impacting its stock price is perception. Now, the market views Alphabet as a leader in search through its reimagined Chrome and Gemini. Google’s TPUs are recognized as a leading method for training AI models, opening a new revenue stream for Alphabet by selling TPUs to hyperscalers.

Alphabet is a textbook example of the upside potential that comes with investing in dirt cheap growth stocks rather than simply betting big on red-hot highfliers. When growth expectations are virtually nonexistent, a company doesn’t have to do much to garner a favorable response from Wall Street.

If we examine Alphabet’s timeline over the last six or so months, I would say that a significant change occurred in late summer and fall, when Alphabet began to be recognized as a major player in AI rather than a laggard. The recent run-up over the last few weeks is attributed to a positive response to Gemini 3, which was announced in mid-November, and news that Meta was interested in buying TPU chips.

These announcements are undoubtedly great news for Alphabet investors, but they didn’t emerge from nowhere. Alphabet’s Google Search and Gemini results have been exceptional for several quarters. Alphabet and Broadcom’s seventh-generation TPU is 30 times more powerful than the first cloud TPU from 2018. But still, the partnership has been going on for a while now.

Alphabet remains a solid buy now

Alphabet has room to run in 2026 because its valuation is still reasonable at 30 times forward earnings. With multiple levers to pull to grow earnings, Alphabet is a balanced buy now. But it isn’t the dirt cheap value stock it used to be. Now, Alphabet is at a similar valuation to peers like Microsoft and Amazon, and more expensive than Meta Platforms.

All told, Alphabet is a great example of why there’s a lot of money to be made in the stock market if you can find quality companies that are mispriced because fears are overshadowing fundamentals and growth potential.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Here’s why Alphabet is the best-performing “Magnificent Seven” stock in 2025 (and why it has room to run in 2026) appeared first on The Motley Fool Australia.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

More reading

• Prediction: This will be the world’s largest company by year-end 2026 (Hint: It’s not Nvidia)
• Better $3 trillion AI stock to buy now: Microsoft or Alphabet
• What are the 5 top artificial intelligence (AI) stocks to buy right now?
• Screaming buy? This ASX ETF has returned 54% a year since 2022
• Warren Buffett is buying artificial intelligence (AI) stocks while Michael Burry is shorting them — Who’s right?

Daniel Foelber has positions in Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Advanced Micro Devices, Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, and Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Broadcom and has recommended the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has recommended Advanced Micro Devices, Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It’s no surprise to me that the best Australian stocks are able to outperform the ASX share market. Quality is appealing for a reason.

Investing in great businesses seems like a winning formula, in my opinion. They can continue re-investing the generated profit into great opportunities inside their existing operations which are already performing well.

Following recent share price declines, I believe both of the Australian stocks below are compelling investments that I’d happily put $10,000 into today.

Washington H. Soul Pattinson and Co. Ltd (ASX: SOL)

This investment conglomerate has been demonstrating its quality for a number of decades and it remains a leading example of how to manage a business for the long-term.

The Australian stock has built an impressive portfolio of assets across a number of industries, including building products, industrial properties, resources, telecommunications, swimming pools, electrification, farming, water entitlements, financial services, credit, healthcare and plenty more.

The business has designed its portfolio to be defensive and generate strong cash flow in all economic conditions for shareholders. This makes it likely the business can continue growing the cash flow its portfolio generates, which is a key statistic of focus, as it invests in additional opportunities.

The Soul Patts share price has dropped close to 20% since 10 September 2025, making it a lot cheaper to grab a piece of this excellent business.

I’m confident the company has a compelling future ahead because of how it can adjust its portfolio when it sees new opportunities arise. Additionally, it can sell assets if it’s no longer optimistic about an investment.

I think this business is likely to be around in another 20, 30 and 50 years thanks to its investment flexibility, while delivering a solid dividend along the way.

Pro Medicus Ltd (ASX: PME)

Pro Medicus describes itself as a leading healthcare informatics company, which provides a full range of medical imaging software and services to hospitals, imaging centres and healthcare groups around the world.

The business aims to provide an end-to-end offering in healthcare imaging across radiology information systems (RIS), picture archiving and communication systems (PACS), AI and e-health solutions.

Pro Medicus’ software is clearly resonating with customers, with the number of large new contracts it’s winning, as well as add-on modules.

For example, at the start of December, the company announced a seven-year, $25 million contract to add another module for Baycare, which is one of Pro Medicus’ largest existing contracts.

The Australian stock has rapidly ramped up its revenue – in FY25 alone, revenue climbed 31.9% to $213 million, while net profit after tax (NPAT) surged 39.2% to $115.2 million.

While revenue growth is strong, the company’s underlying operating profit (EBIT) margin is an extremely high 74% – that’s one of the highest on the ASX. Such a high EBIT margin means most of the revenue translates into profit for the company.

The Pro Medicus share price has dropped more than 20% since September, making its forward price/earnings (P/E) ratio seem more reasonable. It’s now trading at 99x FY28’s estimated earnings, according to the projection on Commsec at the time of writing.

The post 2 strong Australian stocks to buy now with $10,000 appeared first on The Motley Fool Australia.

More reading

• See which companies have just been added to key ASX indices
• 2 ASX giants to buy for decades of growth and dividends
• Could this undervalued ASX stock be your ticket to millionaire status?
• Pro Medicus responds to data breach speculation: no client or patient data accessed
• These ASX innovators could be the market’s next big winners

Motley Fool contributor Tristan Harrison has positions in Pro Medicus and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

You don’t need to wait until you have a big starting balance to build real wealth in the share market.

Plenty of everyday Australians have grown six-figure portfolios not because they started rich, but because they invested consistently, let time do the heavy lifting, and avoided trying to get rich quickly.

Here’s how someone starting with almost nothing can grow a $100,000 portfolio over time.

Where to start

The perfect time to start investing in ASX shares is now. Markets go up, down, sideways, and sometimes all at once. What matters isn’t timing the market; it is the time you spend in the market.

Even a modest weekly or fortnightly contribution into ASX shares can build real momentum surprisingly quickly.

For example, investing just $50 a week, which is an amount that many people spend on takeaway or subscriptions, adds up to $2,600 a year.

Combined with a long-term market return of around 8% to 10% per annum, that can snowball dramatically.

This is the quiet power of compounding. Each dollar you invest works for you, generating returns that begin generating more returns. The earlier you start, the more years you give those dollars to multiply and build wealth.

Choose investments that grow

If the goal is a $100,000 portfolio, your money needs to be working in assets with long-term growth potential. That means avoiding low-yielding savings accounts and instead leaning on high-quality ASX shares or exchanged traded funds (ETFs).

ASX shares like Xero Ltd (ASX: XRO), TechnologyOne Ltd (ASX: TNE), or Lovisa Holdings Ltd (ASX: LOV) are examples of high-growth options.

Alternatively, there are ETFs like the Betashares Nasdaq 100 ETF (ASX: NDQ), the Betashares Global Cybersecurity ETF (ASX: HACK), and the Vanguard Msci Index International Shares ETF (ASX: VGS) that could be worth considering.

How long does it take to reach $100,000?

If you invest $50 a week or the equivalent of $220 a month and earn 10% per annum, your portfolio could hit the following:

• $9,000 in around 3 years
• $50,000 in around 11 years
• $100,000 in roughly 16 years

If you can stretch to $100 a week or $440 a month, you could reach $100,000 in 11 years.

Foolish takeaway

Reaching a $100,000 portfolio isn’t reserved for high-income earners. It is achievable for almost anyone who starts early and invests regularly.

The sooner you start, the sooner you will get there.

The post How to build a $100,000 ASX share portfolio starting at zero appeared first on The Motley Fool Australia.

More reading

• How to invest your first $1,000 in the share market the smart way
• 5 ASX ETFs for beginner investors in 2026 and beyond
• 2 ASX giants to buy for decades of growth and dividends
• The smart way to make a $25,000 passive income from ASX shares
• Top ASX shares to buy now for long-term growth

Motley Fool contributor James Mickleboro has positions in BetaShares Nasdaq 100 ETF, Lovisa, Technology One, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BetaShares Global Cybersecurity ETF, BetaShares Nasdaq 100 ETF, Lovisa, Technology One, and Xero. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF and Xero. The Motley Fool Australia has recommended Lovisa, Technology One, and Vanguard Msci Index International Shares ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.